Lumos Diagnostics Holdings Ltd has released a press release.
Target Market Determination
Filed with ASX ·
Watch Lumos Diagnostics' latest callLumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call · Replay · Apr 20Read the transcript of Lumos Diagnostics Holdings (ASX:LDX) Q3 2026 Earnings Call6ix hasn’t read this filing yet.
Lumos Diagnostics Holdings Ltd. on 6ix
In the deck
Earlier from Lumos Diagnostics
- Operational Update and Accelerated Entitlement Offer
- Operational Review & Management Reorganisation
- FebriDx Update - Brazil Market Authorisation & New Study
- FY2022 Half Year Update
- Lumos Diagnostics FY22 First Half Year Results
Later from Lumos Diagnostics
- Successful Completion of Institutional Entitlement Offer
- Lumos secures initial development services contract
- Lumos Diagnostics Appoints Doug Ward as CEO
- Security Class Suspension from Quotation LDXO
- ViraDx Receives Interim Order Authorisation in Canada
Follow Lumos Diagnostics into a list and get an email when it puts out news.
Follow Lumos Diagnostics